Controversies and Updates in Inflammatory Bowel Disease (Ongoing)

The series on “Controversies and Updates in Inflammatory Bowel Disease” is edited by Dr. Keith Sultan from Department of Gastroenterology, North Shore University Hospital and Long Island Jewish Medical Center, Great Neck, NY, USA.

Read More>>

Reviewer of the Month (2022)

In 2022, TGH reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Read More>>

Interviews with Outstanding Authors (2022)

In 2022, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspectives and insightful views as authors.

Read More>>

Translational Gastroenterology and Hepatology is going to receive its first impact factor in June 2023

According to the latest news of Web of Science, Clarivate Analytics on July 26, 2022, in the 2023 release of the Journal Citation Report™, all Web of Science Core Collection™ journals will receive a Journal Impact Factor (JIF)™. This means expanding the JIF from Science Citation Index Expanded (SCIE)™ and Social Science Citation Index (SSCI)™ to include journals from the Arts and Humanities Citation Index (AHCI)™ and the multidisciplinary Emerging Sources Citation Index (ESCI)™.

Read More>>

Innovation in Endoscopy

Interventional Gastroenterology is a rapidly expanding field at the cutting edge of innovation and novelty. New device technology coupled with improvements in endosonographic and high-definition imaging as well as the advent of carbon dioxide insufflation has led to a revolution in endoscopic therapy. The last decade has seen the emergence and widespread adoption of entirely new fields of endoscopy including therapeutic endoscopic ultrasound (T-EUS), third space endoscopy, and endobariatrics. In addition, new technology has allowed for major advancements in pancreaticobiliary management as well as Barretts Esophagus therapy.

Read More>>

Translational Gastroenterology and Hepatology (TGH) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Translational Gastroenterology and Hepatology (TGH) is among the list of COPE membership.

Read More>>

Liver Transplantation in NASH and ALD

In the last two decades, non-alcoholic fatty liver disease (NAFLD), has transitioned from a non-existent entity to become one of the leading etiologies of chronic liver disease in the world.

Read More>>

Current Topics in Pediatric General Surgery

The shifting paradigm away from individual efforts toward collaboration has resulted in rapid, greater advancements in the care of children in the past 20 years. As is so often the case in medicine, necessity drives innovation. We can only hope that this trend will continue to evolve in the future. The goal continues to be earlier, non-invasive diagnostics with more effective interventions that minimize patient morbidity and maximize patient comfort.

Read More>>

Recent Advances in Rare Liver Diseases

In editing this focused series on the novel advances in rare and undiagnosed liver diseases, we hoped to highlight, using specific examples, the burden of these diseases, their complexity, the unmet needs for the patients and their families, as well as the opportunities to learn more about pathophysiological mechanisms and targets that can also be applied to more common liver diseases.

Read More>>

AME entered an official partnership with Publons to enhance wide-ranging recognition for reviewers

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020. Around 60 AME journals’ peer review systems are now integrated seamlessly into the Publons platform (https://publons.com/about/home). The partnership was done to recognize our expert peer reviewers spontaneously for their review contribution.

Read More>>

Implementation of transparent peer review at Translational Gastroenterology and Hepatology

With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to implement a transparent peer review process as an option for all manuscripts submitted to TGH from March 19, 2020.

Read More>>